IOVA Iovance Biotherapeutics, Inc.

Fundamentals / CIK 0001425205 / USD

Iovance Biotherapeutics, Inc. reported $379.0M in revenue and a net loss of $220.5M for the trailing twelve months ended September 30, 2026 (up 80.1% year over year), with a 53.2% gross margin and a -60.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IOVA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$306.6M$153.3M$0-$437.6MFY 2016 Revenue: $0FY 2016 Net Income: -$52.89M2016FY 2017 Revenue: $0FY 2017 Net Income: -$92.06M2017FY 2018 Revenue: $0FY 2018 Net Income: -$123.6M2018FY 2019 Net Income: -$197.6M2019FY 2020 Net Income: -$259.6M2020FY 2021 Net Income: -$342.3M2021FY 2022 Net Income: -$395.9M2022FY 2023 Revenue: $1.19MFY 2023 Net Income: -$444.0M2023FY 2024 Revenue: $164.1MFY 2024 Net Income: -$372.2M2024FY 2025 Revenue: $263.5MFY 2025 Net Income: -$391.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $263.5M $164.1M $1.19M -- -- -- -- $0 $0 $0
Cost of Revenue $173.2M $93.25M $1.03M -- -- -- -- -- -- --
Gross Profit $90.32M $70.82M $156K -- -- -- -- -- -- --
Research & Development $300.3M $276.2M $333.2M $294.8M $259.0M $201.7M $166.0M $99.83M $71.61M $26.94M
Total Operating Expenses -- -- -- $398.9M $342.7M $261.9M $206.9M $128.3M $92.88M $53.64M
Operating Income -$403.4M -$395.3M -$460.6M -$398.9M -$342.7M -$261.9M -$206.9M -$128.3M -$92.88M -$53.64M
EBITDA -$390.5M -$384.0M -$449.0M -$389.6M -$339.6M -$260.8M -$205.7M -$127.3M -$91.92M -$52.66M
Interest Income $10.31M $20.27M $13.04M $2.98M $451K $2.36M $9.32M $4.68M $813K $745K
Income Before Tax -$393.0M -$375.0M -$447.5M -$395.9M -$342.3M -- -- -- -- --
Income Tax Expense -$2.07M -$2.83M -$3.48M $0 $0 $0 $0 $0 $0 $0
Net Income -$391.0M -$372.2M -$444.0M -$395.9M -$342.3M -$259.6M -$197.6M -$123.6M -$92.06M -$52.89M
Basic EPS -$1.09 -$1.28 -$1.89 -$2.49 -$2.23 -$1.88 -$1.59 -$1.27 -$1.41 -$1.85
Diluted EPS -$1.09 -$1.28 -$1.89 -$2.49 -$2.23 -$1.88 -$1.59 -$1.27 -$1.41 -$1.85
Basic Shares Outstanding 357.3K 289.9K 235.1K 159.3K 153.4K 138.3K 124.3K 97.3K 65.2K 55.3K
Diluted Shares Outstanding 357.3K 289.9K 235.1K 159.3K 153.4K 138.3K 124.3K 97.3K 65.2K 55.3K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $121.5M $99.31M $71.43M $86.77M $67.45M $59.95M $49.32M $73.69M
Cost of Revenue $48.03M $43.59M $42.50M $43.11M $38.48M $48.88M $42.72M $37.79M
Gross Profit $73.44M $55.72M $28.93M $43.66M $28.98M $11.07M $6.61M $35.91M
Research & Development $49.34M $58.85M $62.49M $71.20M $75.17M $77.93M $75.97M $71.01M
Operating Income -$23.97M -$51.91M -$81.04M -$73.46M -$94.90M -$113.8M -$121.2M -$86.58M
EBITDA -$20.17M -$48.12M -$78.22M -$69.74M -$91.71M -$110.4M -$118.7M -$83.30M
Interest Income $2.31M $3.22M $1.33M $1.74M $1.24M $4.10M $3.22M $9.57M
Income Before Tax -$21.66M -$48.69M -$79.71M -$71.72M -$93.66M -$109.7M -$118.0M -$77.00M
Income Tax Expense $614K -$1.37M -$665K $184K -$2.40M $1.99M -$1.84M $1.56M
Net Income -$22.27M -$47.31M -$79.05M -$71.90M -$91.25M -$111.7M -$116.2M -$78.56M
Basic EPS -$0.05 -$0.11 -$0.19 -- -$0.25 -$0.33 -$0.36 --
Diluted EPS -$0.05 -$0.11 -$0.19 -- -$0.25 -$0.33 -$0.36 --
Basic Shares Outstanding 455.9M 450.2K 418.5K -- 364.0M 334.5K 322.9K --
Diluted Shares Outstanding 455.9M 450.2K 418.5K -- 364.0M 334.5K 322.9K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $163.1M $115.7M $114.9M $231.7M $78.23M $67.33M $13.97M $82.15M $145.4M $106.7M
Short-Term Investments $133.9M $208.1M $165.0M $240.1M $426.2M $562.1M $293.1M $386.4M -- --
Cash & Short-Term Investments $297.0M $323.8M $279.9M $471.8M $504.4M $635.0M $307.1M $386.4M $0 $166.5M
Accounts Receivable, Net $82.45M $69.34M $151K -- -- -- -- -- -- --
Inventory $51.68M $51.52M $10.37M -- -- -- -- -- -- --
Total Current Assets $442.7M $457.0M $307.8M $479.1M $508.0M $636.1M $316.5M $475.4M $149.3M $169.5M
Property, Plant & Equipment, Net $131.1M $109.1M $114.0M $105.2M $100.9M $59.16M $8.54M $2.68M $2.45M $2.37M
Intangible Assets $279.3M $282.4M $229.3M -- -- -- -- -- -- --
Long-Term Investments -- -- -- -- $91.59M -- -- -- -- --
Other Non-Current Assets $8.17M $369K $270K $189K $1.78M $12.92M $3.48M $2.76M $3.63M $0
Total Non-Current Assets $470.5M $453.4M $472.5M $184.9M $269.4M $132.4M $28.16M $5.45M $6.08M $2.37M
Total Assets $913.2M $910.4M $780.4M $664.0M $777.3M $768.5M $344.7M $480.8M $155.4M $171.9M
Accounts Payable $22.16M $27.51M $33.12M $26.60M $27.38M $13.51M $15.57M $2.74M $1.23M $863K
Total Current Liabilities $138.4M $122.3M $110.3M $91.48M $89.20M $54.87M $39.08M $14.40M $9.60M $4.97M
Other Non-Current Liabilities -- -- -- -- -- $11.71M $2.35M $230K -- --
Total Non-Current Liabilities $76.23M $77.68M $85.43M $72.86M $66.47M $57.09M $6.60M $230K $297K $0
Total Liabilities $214.6M $200.0M $195.7M $164.3M $155.7M $112.0M $45.68M $14.63M $9.89M $4.97M
Total Debt (incl. Leases) $48.44M $57.26M $74.86M $84.45M $70.53M $51.66M $11.50M -- -- --
Common Stock $17K $13K $11K $8.0K $7.0K $6.0K $5.0K $5.0K $3.0K $3.0K
Retained Earnings -$2.78B -$2.38B -$2.01B -$1.57B -$1.17B -$830.2M -$570.6M -$372.8M -$249.2M -$157.1M
Accumulated Other Comp. Income $16.44M -$1.05M $2.53M -$902K -$601K $19K $220K -$42K $0 $29K
Total Stockholders' Equity $698.6M $710.4M $584.6M $499.6M $621.7M $656.5M $299.0M $466.2M $145.5M $166.9M
Total Equity $698.6M $710.4M $584.6M $499.6M $621.7M $656.5M $299.0M $466.2M $145.5M $166.9M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $57.93M $110.8M $196.5M $163.1M $158.1M $132.5M $171.7M $115.7M
Short-Term Investments $318.4M $186.9M $116.9M $133.9M $142.7M $168.7M $188.0M $208.1M
Cash & Short-Term Investments $376.3M $297.7M $313.4M $297.0M $300.8M $301.2M $359.7M $323.8M
Accounts Receivable, Net $107.0M $102.1M $81.76M $82.45M $66.76M $59.94M $70.94M $69.34M
Inventory $55.22M $55.59M $58.38M $51.68M $51.71M $49.83M $65.55M $51.52M
Total Current Assets $549.6M $464.3M $466.5M $442.7M $429.1M $422.5M $512.6M $457.0M
Property, Plant & Equipment, Net $129.3M $131.5M $131.4M $131.1M $126.7M $122.5M $111.6M $109.1M
Intangible Assets $259.2M $263.9M $269.1M $279.3M $285.2M $296.3M $285.4M $282.4M
Other Non-Current Assets $4.48M $6.43M $8.29M $8.17M $9.27M $10.32M $426K $369K
Total Non-Current Assets $441.6M $451.3M $459.2M $470.5M $475.9M $484.9M $454.1M $453.4M
Total Assets $991.2M $915.5M $925.7M $913.2M $904.9M $907.4M $966.7M $910.4M
Accounts Payable $21.64M $26.21M $37.45M $22.16M $31.24M $32.00M $28.49M $27.51M
Total Current Liabilities $105.8M $106.8M $129.4M $138.4M $125.8M $129.2M $122.7M $122.3M
Total Non-Current Liabilities $72.78M $72.64M $74.49M $76.23M $76.88M $79.79M $76.18M $77.68M
Total Liabilities $178.6M $179.5M $203.9M $214.6M $202.7M $208.9M $198.9M $200.0M
Total Debt (incl. Leases) $45.21M $46.00M $46.78M $48.44M $51.49M $52.17M $52.72M $57.26M
Common Stock $19K $19K $18K $17K $16K $14K $14K $13K
Retained Earnings -$2.92B -$2.90B -$2.85B -$2.78B -$2.70B -$2.61B -$2.50B -$2.38B
Accumulated Other Comp. Income $13.85M $13.08M $12.65M $16.44M $16.10M $20.86M $6.29M -$1.05M
Total Stockholders' Equity $812.7M $736.0M $721.8M $698.6M $702.3M $698.5M $767.9M $710.4M
Total Equity $812.7M $736.0M $721.8M $698.6M $702.3M $698.5M $767.9M $710.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$391.0M -$372.2M -$444.0M -$395.9M -$342.3M -$259.6M -$197.6M -$123.6M -$92.06M -$52.89M
Depreciation & Amortization $12.86M $11.26M $11.57M $9.31M $3.11M $1.14M $1.17M $956K $952K $978K
Stock-Based Compensation $61.58M $109.6M $62.62M $84.02M $69.77M $40.89M $24.28M $20.03M $11.97M $18.90M
Change in Receivables -$13.11M -$69.19M -$149K -- -- -- -- -- -- --
Change in Inventory -$14.21M -$44.38M -$10.12M -- -- -- -- -- -- --
Change in Payables -$6.66M -$7.84M $4.83M $5.88M $6.98M -$2.96M $12.71M $1.51M $369K -$250K
Operating Cash Flow -$302.4M -$353.0M -$361.8M -$292.8M -$227.9M -$205.1M -$158.9M -$101.2M -$78.71M -$32.67M
Capital Expenditure -$33.84M -$11.07M -$22.29M -$20.43M -$37.57M -$46.79M -$6.92M -$1.20M -$1.03M -$1.52M
Free Cash Flow -$336.2M -$364.0M -$384.1M -$313.2M -$265.5M -$251.9M -$165.8M -$102.4M -$79.74M -$34.19M
Acquisitions, Net -- -- -$212.6M -- -- -- -- -- -- --
Purchases of Investments -$318.7M -$460.8M -$205.9M -$245.8M -$725.2M -$947.7M -$417.7M -$426.1M -- --
Investing Cash Flow $47.50M -$96.41M -$155.2M $256.5M $132K -$317.9M $90.03M -$386.3M $58.68M $8.89M
Common Stock Issued $306.3M $397.3M $463.3M $189.5M $203.2M $567.0M -- $398.8M $53.66M $95.69M
Financing Cash Flow $300.8M $390.7M $463.0M $190.2M $239.3M $576.4M $6.13M $424.3M $58.69M $96.90M
Net Change in Cash $47.01M -$59.27M -$56.84M $153.8M $11.46M $53.44M -$62.73M -$63.22M $38.66M $73.13M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$22.27M -$47.31M -$79.05M -$71.90M -$91.25M -$111.7M -$116.2M -$78.56M
Depreciation & Amortization $3.80M $3.78M $2.82M $3.72M $3.19M $3.40M $2.57M $3.27M
Stock-Based Compensation $11.83M $11.73M $11.27M $11.82M $11.90M $14.94M $22.91M $30.98M
Change in Receivables -$4.87M -$20.36M $690K -$15.69M -$6.82M $11.00M -$1.60M -$13.57M
Change in Inventory $596K -$177K -$4.93M -$4.00M -$3.02M $6.65M -$13.83M -$18.93M
Change in Payables -$2.60M -$11.82M $15.89M -$5.21M -$4.39M $893K $2.05M -$6.07M
Operating Cash Flow -$4.47M -$60.84M -$72.07M -$52.56M -$78.70M -$67.45M -$103.7M -$73.30M
Capital Expenditure -$4.74M -$5.44M -$6.61M -$9.32M -$10.84M -$7.46M -$6.21M -$4.17M
Free Cash Flow -$9.21M -$66.28M -$78.68M -$61.88M -$89.55M -$74.91M -$109.9M -$77.46M
Purchases of Investments -$186.8M -$129.6M -$56.00M -$59.91M -$92.14M -$68.70M -$97.92M -$88.16M
Investing Cash Flow -$134.6M -$74.05M $11.39M $775K $17.01M $13.84M $15.87M $23.68M
Common Stock Issued $87.90M $49.57M $98.51M $55.78M $88.52M $13.06M $148.9M $0
Financing Cash Flow $86.28M $49.29M $94.33M $56.17M $88.06M $13.23M $143.3M $2.31M
Net Change in Cash -$52.82M -$85.73M $33.44M $4.96M $25.69M -$39.64M $56.00M -$48.49M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 34.3% 43.2% 13.1% -- -- -- -- -- -- --
Operating Margin -153.1% -240.9% -38735.0% -- -- -- -- -- -- --
Net Profit Margin -148.4% -226.8% -37345.4% -- -- -- -- -- -- --
Return on Equity (ROE) -56.0% -52.4% -76.0% -79.2% -55.1% -39.5% -66.1% -26.5% -63.3% -31.7%
Return on Assets (ROA) -42.8% -40.9% -56.9% -59.6% -44.0% -33.8% -57.3% -25.7% -59.3% -30.8%
Current Ratio 3.20x 3.74x 2.79x 5.24x 5.69x 11.59x 8.10x 33.02x 15.56x 34.12x
Quick Ratio 2.83x 3.31x 2.70x 5.16x 5.65x 11.57x 7.86x 26.84x 0.00x 33.51x
Debt to Equity 0.07x 0.08x 0.13x 0.17x 0.11x 0.08x 0.04x -- -- --
Revenue Growth (YoY) +60.6% +13699.0% -- -- -- -- -- -- -- --
Gross Profit Growth (YoY) +27.5% +45298.7% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 53.2% 48.4% 39.4% 34.3% 33.0% 33.4% 32.6% 34.2%
Operating Margin -60.8% -92.7% -127.2% -153.1% -166.3% -170.0% -187.5% -240.9%
Net Profit Margin -58.2% -89.1% -123.9% -148.4% -158.8% -161.4% -176.5% -226.8%
Return on Equity (ROE) -27.1% -39.3% -49.0% -56.0% -56.6% -55.8% -48.9% -52.4%
Return on Assets (ROA) -22.2% -31.6% -38.2% -42.8% -43.9% -43.0% -38.8% -40.9%
Current Ratio 5.20x 4.35x 3.60x 3.20x 3.41x 3.27x 4.18x 3.74x
Quick Ratio 4.67x 3.82x 3.15x 2.83x 3.00x 2.89x 3.64x 3.31x
Debt to Equity 0.06x 0.06x 0.06x 0.07x 0.07x 0.07x 0.07x 0.08x
Revenue Growth (YoY) +80.1% +65.7% +44.8% +17.7% +15.2% +92.7% +6798.5% --
Gross Profit Growth (YoY) +153.4% +403.3% +337.8% +21.6% +7.2% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001425205) · from December 31, 2008 Data through September 30, 2026 · synced Nov 20, 2026, 05:18 UTC · Open in terminal